« M2 Presswire - Novartis receives FDA approvable letter for Diovan (valsartan) for the treatment of heart failure in patients not on an ACE inhibitor.
MMR - FDA approves Diovan »

Internal Medicine News - Higher dose of Diovan HCT approved

The FDA has approved the higher-dose formulations of Diovan HCT (valsartan/hydrochlorothiazide) for patients with high blood pressure. The medication is a combination of Diovan (valsartan), an angiotensin receptor blocker, and the diuretic hydrochlorothiazide, and is now available in 320-mg/12.5-mg and 320-mg/25-mg tablets.

Related Results

DiovanDiovanDiovan dosesFDA approves DiovanNew indication for diovan

For more information, visit www.pharma.us.novartis.com and click on “Prescribing Information.”
COPYRIGHT 2006 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning